Table of Contents Table of Contents
Previous Page  53 / 78 Next Page
Information
Show Menu
Previous Page 53 / 78 Next Page
Page Background

DCMS online

. org

Northeast Florida Medicine

Vol. 66, No. 4 2015

53

Inflammatory Bowel Disease

Hemorrhage:

This is a rather uncommon event. Usually there are mini-

mally bloody stools, but hematochezia is not severe enough to

require surgical intervention or transfusion. However, some

chronic bleeding can cause persistent anemia. Significant

hemorrhage may be difficult to diagnose. Physicians need to

use bleeding scans, angiography and endoscopic procedures

to try to localize the site of bleeding. Unfortunately these

techniques are often unable to find the exact locations of

bleeding. Sometimes a physician has to resort to intraop-

erative enteroscopy or colonoscopy to ascertain the site of

bleeding, with a surgeon helping to advance the scope.

Carcinoma:

Crohn’s disease is a precancerous disease and the patient

will have a 4-20 times higher chance of developing cancer

in the affected portion of the intestine.

10

However, the

incidence of small bowel cancer, in general, is so low that

very few patients will have the disease. The most common

site for adenocarcinoma of the small intestine is in the

distal ileum. Any stricture must be examined to exclude

the possibility of carcinoma or dysplasia. The diagnosis

of small bowel carcinoma remains a challenge. Many of

these patients will be diagnosed at the time of laprotomy

or in the resected specimen. The incidence increases in the

bypassed segment from previous surgery. Therefore, even

the non-functioning rectal stump should be either excised

or the function restored. There is a 70 percent chance of

lymph node involvement at the time of initial diagnosis.

11

Therefore, overall prognosis remains poor.Treatment remains

resection for adenocarcinoma of the small intestine or colon.

If high grade dysplasia is diagnosed in Crohn’s disease, four

patients out of 10 (40 percent) had multifocal dysplasia at

remote sites.

6

In view of this, in a low risk, healthy patient,

total proctocolectomy should be considered.

Crohn’s colitis and toxic megacolon:

Many times these patients do not carry a well-established

diagnosis, whether it is ulcerative colitis or Crohn’s disease.

It is very important to establish correct diagnosis before

proceeding for a major proctocolectomy and ileoanal

pouch construction. The pouch failure rate in ileoanal

disease is up to 30 percent.

12

Ideally, a segmental resection

is advisable. If the disease is limited to the right colon, a

right hemicolectomy will suffice. If the disease is in the left

colon, a segmental resection should be performed to avoid

colostomy. The recurrence rate is 60 percent at five years.

13

It has been shown that when the disease is limited to the

colon without small bowel involvement, it does not recur

in the small intestine after proctocolectomy.

Toxic megacolon is not common inCrohn’s disease. How-

ever, if encountered and a short course of medical therapy

fails to treat the condition, a physician should be aggressive

with surgical intervention. Perforation in Crohn’s toxic

megacolon has up to a 45 percent mortality rate.

10

If there

is concomitant severe perineal infection at the same time, it

is best to avoid proctectomy at the initial surgery. Otherwise

it can result in perineal wound and severe sepsis. In these

cases, and when no clear diagnosis is established, abdominal

colectomy and ileostomy should be carried out initially.

Pregnancy and surgery in Crohn’s disease:

Usually these patients plan pregnancy when the disease

is inactive. If there is flare, medical treatment is carried out

aggressively. For surgical complications, MRI, ultrasound,

colonoscopy and other imaging techniques are used, depend-

ing upon the severity of the condition. Surgical treatment is

carried out based on the diagnosis. These patients do carry

a higher chance of developing anorectal suppuration and

genitourinary fistulas.

Intestinal transplant:

This a rare, difficult and challenging procedure with po-

tential for rejection even after immunosuppressive drugs. It

should only be performed in a highly selected patient who

has rather terminal bowel disease. Most of the intestine has

been resected prior to the transplant. There have been case

reports of patients developing Crohn’s disease eight years

post-transplant in the transplanted intestine.

14

Conclusion:

Even with the advent of ever-evolving newer drugs and

medical management of Crohn’s disease, surgery remains

an integral part of treatment to help patients improve and

continue with a better lifestyle. Management should be

carried out in close association with a gastroenterologist.

As much as possible, surgeons should use bowel sparing

procedures via minimally invasive techniques. Aggressive

surgical treatment should be carried out in conditions

causing septic complications.

v